Medicoz Community

Viral Meningitis in Paediatric Patient

Case Presented by : Situpriya Rout , 2nd Year MBBS , AIIMS Kalyani    Patient Information Name: Master A.R. Age: 6 years Gender: Male Address: Kalyani, West Bengal Date of Admission: [Date] Hospital ID: [ID Number] Presenting Complaints High-grade fever for 3 days. Severe headache for 2 days. Vomiting, 2 episodes in the last 24 […]

CASE PUBLICATIONS

Asthma in Obese Patients : Challenges and Outcomes

Presented by : Aarzoo Ali Kaif , 2nd Year MBBS , AIIMS Kalyani ( Medicoz Community Editors Pick )♦♦♦ Patient Profile: Name: Arpita Ghosh Age: 45 years Gender: Female Occupation: Homemaker Location: Kalyani, West Bengal, India BMI: 36 kg/m² (Obese, Class II) Medical History: Diagnosed with asthma at age 30 Hypertension, Type 2 Diabetes Mellitus […]

CASE PUBLICATIONS

NExT or NEET PG: Your Pathway to Medical Excellence with Medicoz Community

Next or NEET PG: Your Pathway to Medical Excellence with Medicoz Community Are you a medical student or a recent graduate aspiring to become a highly skilled and successful doctor? If so, you’ve probably heard about the Next or NEET PG exams, the stepping stones to postgraduate medical education in India. Preparing for these competitive […]

NEET PG / NEXT

Crack NEET PG 2023 – Last Minute guide by Medicoz Community

Crack Neet PG 2023 with Medicoz Community. Last Minute Tips to Crack NEET PG 2023 To GIVE YOUR 100%. • National Eligibility Cum Entrance Examination-Post Graduate (NEET PG) is a medical entrance exam that goes around in the mind of every MBBS students all the time, and getting a good rank to secure an MD/MS […]

NEET PG / NEXT, Recent Updates

WHO GUIDELINES 2022 – For Drug Resistant Tuberculosis

WHO GUIDELINES 2022 – For Drug Resistant Tuberculosis WHO in a landmark move has updated the initial treatment regime for all eligible people diagnosed with multidrug-resistant or rifampicin-resistant TB (MDR/RR-TB). The recommendation includes a shorter 6-month regime comprising bedaquiline (Bdq), pretomanid, linezolid (Lzd) and moxifloxacin (Mfx) i.e BPaLM. The previous longer 9-month BPaL regime is […]

Community Medicine Update

National Suicide Prevention Strategy – Medicoz Community

National Suicide Prevention Strategy : Suicide is the leading cause of death among individuals between 15-29 years of age in India. With an increase in the rate of suicide from 10.2 to 11.3 per 1 one lakh population in the past 3 years, the MOHFW has rolled out the first National Suicide Prevention Strategy (NSPS). […]

Community Medicine Update

Osteseconazole: First FDA-approved drug for recurrent vulvovaginal candidiasis

Osteseconazole: First FDA-approved drug for recurrent vulvovaginal candidiasis Around 75% of all adult women will have at least 1 yeast infection during their lifetime. About half of them will have a recurrence of the condition and 9% of them may develop recurrent vulvovaginal candidiasis (RVVC). According to CDC, RVVC is defined as three or more […]

FDA Approvals

Gut Microbiome Can Alter Cancer Therapy Response – Medicoz Community

Gut Microbiome Can Alter Cancer Therapy Response – Medicoz Community Researchers found that sequencing technology has shown that the gut microbiome plays a role in the treatment of cancer, apart from other benefits. The findings published in JAMA Oncology established the current understanding of the connection between the gut microbiome and therapeutic response to immunotherapy […]

Medical News

FDA Approved New Med for Lennox – Gastaut Syndrome

Gastaut Syndrome – FDA Approved New Med for Lennox The US Food and Drug Administration (FDA) has approved fenfluramine (Fintepla) oral solution, a Schedule IV controlled substance, for the treatment of seizures associated with Lennox-Gastaut syndrome (LGS) in children aged 2 years and older, the company has announced. Fenfluramine is already approved in the US […]

New Drug Approvals
Sorry this site disable right click
Sorry this site disable selection
Sorry this site is not allow cut.
Sorry this site is not allow copy.
Sorry this site is not allow paste.
Sorry this site is not allow to inspect element.
Sorry this site is not allow to view source.